Vaccine Science

What Is Subclade K? The Flu Strain That Changed the 2026 Vaccine

By Published

Quick answer: Subclade K is a branch of influenza A(H3N2) that emerged late in Australia’s 2025 season and helped push it well past its usual finish. It is an example of antigenic drift — the reason flu vaccines are rebuilt every year rather than made once.

If you saw “subclade K” in the news and wondered whether your team ended up with the wrong vaccine this winter, this is the short version of what actually happened.

What subclade K is, and what it isn’t

Influenza A is divided into subtypes. The two that circulate in people are A(H1N1) and A(H3N2). Within a subtype, the virus keeps splitting into smaller branches, and “subclade K” is the informal name that stuck to one branch of A(H3N2).

It is not a new disease and not a new kind of flu. It is the same influenza A that Australian workplaces see every winter, changed enough from the previous season’s vaccine strain to behave differently.

Why Australia’s 2025 season ran so long

Australia’s 2025 season did not taper off through spring the way an influenza season usually does. The surveillance write-up in Eurosurveillance — published under the title Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses — describes “an unusually long season stretching from May to November (opens in new tab)“.

A season that keeps climbing when it should be finishing is what put the name in the news.

Why flu strains change at all

This has a proper name, and it is worth knowing because it explains everything that follows. The Australian Immunisation Handbook calls it antigenic drift: the surface of the virus changes in small steps, season after season, until it no longer matches what the vaccine was built against.

  • Matched

    The vaccine is built to match

    Each season’s vaccine is built against the strains global surveillance expects to circulate.

  • Drifted

    The surface changes in small steps

    Those small changes build up season after season, until the strain is no longer a close match for the vaccine.

  • Rebuilt

    The composition is reviewed

    A closer-matching strain is chosen for the next season. That is what happened to the A(H3N2) component for 2026.

That drift is precisely why the vaccine is rebuilt each year instead of made once. In the Handbook’s words, “the composition of influenza vaccines needs to be reviewed every year because of antigenic drift (opens in new tab)“.

So a strain moving is not the system failing. It is the thing the system was built around.

Did the 2026 vaccine change because of it?

The strains are named publicly every year, so this one is checkable rather than a matter of opinion.

The 2025 southern-hemisphere vaccine carried an A(H3N2) component based on A/Croatia/10136RV/2023 — the strain Eurosurveillance names when it describes “the 2025 southern hemisphere recommended vaccine (opens in new tab)“.

For 2026, the Australian Influenza Vaccine Committee recommended a different A(H3N2) strain: A/Singapore/GP20238/2024 for egg-based vaccines, and A/Sydney/1359/2024 for cell-based ones. Both are listed in the Committee’s published recommendations “for the 2026 southern hemisphere trivalent influenza vaccines in Australia (opens in new tab)“.

So the answer to “did we get last year’s vaccine?” is no. The A(H3N2) component of the 2026 Australian flu vaccine is a different strain from the one used in 2025, chosen and published before supply reached the market.

One other change gets confused with this, so it is worth separating. Australia’s 2026 vaccine protects against three strains rather than four — NCIRS describes the “transition from quadrivalent to trivalent formulations (opens in new tab)” — because one influenza B strain, B/Yamagata, has not been detected anywhere in the world since 2020.

Dropping a strain that no longer circulates is a separate decision from updating one that does. More on how each year’s strains are chosen is in our guide to what goes into the vaccine.

What this means for your workplace

Three practical things.

  • There is nothing to request. The strain mix is set by the World Health Organisation and the Australian Influenza Vaccine Committee before supply reaches the market. There is no “subclade K version” to ask for — it is already what the 2026 A(H3N2) component reflects.
  • The clinic date does more work than the strain name. The Handbook describes the antibodies a flu vaccine produces as ones that “reduce infection or severe illness due to influenza (opens in new tab)“. Those are two different jobs, and neither of them starts until people are actually vaccinated.
  • If someone on your team asks, the answer is short. The vaccine is rebuilt every year against what is actually circulating, and this year’s A strain is not last year’s. That is the system doing its job, which is worth saying plainly to anyone who has seen a strain name in a headline.

Planning this winter’s clinic? We run workplace flu vaccination programs across Australia — on-site, or by voucher for teams that are remote or past the on-site window. Talk to us about dates.

Sources

  • Australian Immunisation Handbook — Influenza (flu) chapter: antigenic drift, and annual review of vaccine composition
  • Therapeutic Goods Administration — AIVC recommendations for the composition of influenza vaccines for Australia in 2026
  • Eurosurveillance — Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses
  • NCIRS — 2026 influenza vaccine changes: ATAGI advice and NCIRS resources

Vaccine Science

8 Myths About the Flu and the Flu Vaccine

Debunking 8 common flu vaccine myths. The flu shot cannot make you sick, antibiotics don't cure influenza, and Vitamin C won't prevent it. Get the facts.

Vaccine Science

3 Common Misconceptions About Corporate Flu Jabs

Three things people get wrong about workplace flu vaccination - and the plain answers to give your employees, checked against Australian health guidance.

Vaccine Science

Influenza A vs B in Australia: What Employers Need to Know This Season

There is no reliably worse type — in Australian hospital data, influenza A and B send people to intensive care and cause death at similar rates, and either one can knock a healthy adult flat for a…

Vaccine Science

Can I Get the Flu Vaccine if I’m Allergic to Eggs?

Yes. For most Australians with egg allergy, including a history of anaphylaxis, the inactivated flu vaccine is considered safe (AIH 2026).

Vaccine Science

Four Reasons to Get the Flu Shot Each Year

A yearly flu shot lowers your odds of catching influenza, cuts the chance you pass it to colleagues, family or vulnerable people, and means you keep your week instead of losing one in bed.

Vaccine Science

Can the Flu Shot Give You the Flu? Why You Got Sick

The most likely reason you got sick after your flu shot is a different respiratory virus you caught around the same time.

Vaccine Science

Understanding the Flu Vaccine for the Southern Hemisphere

Get the latest information on Influenza for the Southern Hemisphere, including the latest flu strains and Corporate Care's flu programs.

Corporate Care acknowledges the Traditional Custodians of the lands across Australia on which we work and live. We pay our respects to Elders past and present, and recognise their continuing connection to land, waters and community.